Skip to main content


Showing posts from May 4, 2008

Health or Wealth? What About Both?

"The first wealth is health."
- Ralph Waldo Emerson

Given my experience of the last 2-plus years and the fight to overcome lymphoma, I have become much more aware of the value of maintaining health. And one of the positive outcomes of my cancer survival is that I am 80 pounds lighter than I was in my immediate pre-cancer days. It is believed that this significant weight loss may well help to cure my type 2 diabetes, a malady that beset me about one year before the discovery of the lymphoma in March 2006.
One of those who connected to me through the Internet and my cancer survival is a Canadian lecturer and fellow survivor whom I would like to introduce to my blog readers and direct you to her site (see @ltaLINK below). ..........
Want to increase your health and energy,
feel great about yourself and look your best?

Good news...

Let proud cancer survivor, Roslyn Franken, show you how with the 9 principles that changed her life and can now change your life too!

BiovaxID NHL Vaccine Phase 3 Trial to Stop

Biovest International, Inc. BVTI, a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. ABPI, on April 24 announced that its Chairman and CEO, Dr. Steven Arikian, is scheduled for numerous media interviews regarding the next steps for its cancer vaccine breaktrhough, BiovaxID.

Dr. Arikian commented, "Based on our recent news, it is not surprising that we are being asked to participate in media interviews and present at key investor events. I believe it is fair to say that BiovaxID is on track to potentially become the first ever cancer vaccine approved in the U.S. and/or Europe, initially targeting the treatment of non-Hodgkin's lymphoma (NHL), an insidious and often fatal cancer. The independent Data Monitoring Committee (DMC) just last week recommended stopping our Phase 3 clinical trial early and unblinding the results. The DMC has offered to meet with the FDA to assist in presenting the data and discussing accelerated and/or conditional approval. We are in the p…